ǥ :
|
ȣ - 540611 255 |
Impact of antihypertensive therapy on dyssynchrony in patients with never-treated and uncomplicated hypertension |
가톨릭 의과대학 성바오로 병원 |
권범준, 최규영, 김동빈, 장성원, 조은주, 윤호중, 이만영, 정욱성, 승기배, 노태호, 김재형 |
Background: The impact of antihypertensive therapy on dyssynchrony in patients with never-treated and uncomplicated hypertension has not been explored.
Methods: Fourty two patients of never-treated and uncomplicated hypertension (47.6% men, mean age 55.6 ± 9.9 years) underwent echocardiographic evaluations of dyssynchrony at baseline and after 6 months of antihypertensive therapy. Measured parameters were as follows: i) standard deviation of time from ECG Q to systolic peak velocity of 12 Left ventricular (LV) segments (ms, Ts-SD12) and maximum difference of time to systolic peak velocity among 12 LV segments (ms, Ts-Max) (systolic dyssynchrony); (ii) sum of time exceeding aortic closure in strain curves of 12 LV segments (ms, oExcT) (contractile diastolic dyssynchrony); (iii) SD of time from ECG Q to early diastolic peak velocity of 12 LV segments (ms, Te-SD12) and maximum difference of time to early diastolic velocity among 12 LV segments (ms, Te-Max) (diastolic dyssynchrony). Ts-SD12 ≥33ms or Ts-Max ≥100ms was regarded as systolic dyssynchrony. Patients with systolic dyssynchrony (group 1, N=18) and without systolic dyssynchrony (group 2, N=24) at baseline were compared.
Results: The echocardiographic parameters were summarized in the table. In group 1 patients, systolic (Ts-SD12, Ts-Max) and diastolic (Te-Max) dyssynchrony, and LV mass index (LVMI) significantly improved after antihypertensive therapy. However, there were no significant differences except oExcT in group 2 patients.
Conclusions: Antihypertensive therapy could reverse the echocardiographic parameters of dyssynchrony in patients with hypertension and systolic dyssynchrony.
|
|
Dyssynchrony
at baseline (N=18) |
No Dyssynchrony
at baseline (N=24) |
Total population
(N=42) |
baseline |
Follow-UP |
P value |
baseline |
Follow-UP |
P value |
baseline |
Follow-Up |
P value |
Ts-SD12 (ms) |
44.4±8.7 |
33.4±11.1* |
0.008 |
23.3±7.8 |
26.2±15.3 |
0.596 |
32.3± 13.3 |
29.3± 14.0 |
0.225 |
Ts-Max (ms) |
120.7±30.0 |
97.1±38.2* |
0.011 |
68.3±26.2 |
77.1±46.0 |
0.454 |
90.8± 85.6 |
85.6± 43.5 |
0.132 |
oExcT (ms) |
525.4±309.9 |
416.9±215.4 |
0.270 |
576.7±313.6 |
412.5±160.8* |
0.017 |
554.7± 309.1 |
414.4± 183.7* |
0.013 |
Te-SD12 (ms) |
23.9±13.1 |
18.4±5.1 |
0.087 |
23.3± 13.6 |
24.5± 12.3 |
0.605 |
23.6± 13.2 |
21.9± 10.2 |
0.380 |
Te-Max (ms) |
80.8±57.2 |
57.2±14.1* |
0.031 |
72.7±39.3 |
76.8±39.0 |
0.559 |
76.1± 41.1 |
68.4± 32.1 |
0.220 |
LVMI
(g/m2) |
102.3±32.4 |
91.6±25.3* |
0.037 |
103.6±26.5 |
97.3±27.3 |
0.237 |
103.1±94.8 |
94.8± 26.3* |
0.025 |
ESV (ml) |
22.5±7.8 |
21.9±7.5 |
0.782 |
21.4±9.7 |
22.2±8.0 |
0.663 |
21.9±8.9 |
22.0±7.7 |
0.911 |
EF (%) |
65.8±5.4 |
65.4±6.0 |
0.797 |
66.1±6.7 |
63.1±8.3 |
0.095 |
65.9±6.1 |
64.1±7.4 |
0.115 |
HR (BPM) |
69±8 |
68±12 |
0.721 |
70±10 |
71± 10 |
0.538 |
69±9 |
69±4 |
0.927 |
*P<0.05 compared with baseline
|
|
|